SCHEMBL30769301

SCHEMBL30769301

C[C@@H]1CCc2cc(O)ccc2[C@@H]1c1ccc(N2CCC(C=O)CC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 15/20 0.43
ESR2 Q92731 14/20 0.43
CRBN Q96SW2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30769087 1.00 ESR1 (0.43) ESR1ESR2CRBN
SCHEMBL30769026 0.87 ESR1 (0.47) ESR1ESR2CRBN
SCHEMBL30769315 0.87 ESR1 (0.47) ESR1ESR2CRBN
SCHEMBL30769306 0.86 ESR1 (0.45) ESR1ESR2CRBN
SCHEMBL30768419 0.86 ESR1 (0.41) ESR1ESR2CRBN
SCHEMBL30768792 0.86 ESR1 (0.45) ESR1ESR2CRBN
SCHEMBL30768821 0.86 ESR1 (0.41) ESR1ESR2CRBN
SCHEMBL30768888 0.86 ESR1 (0.41) ESR1ESR2CRBN
SCHEMBL30769167 0.86 ESR1 (0.41) ESR1ESR2CRBN
SCHEMBL27081332 0.86 ESR1 (0.44) ESR1ESR2CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543871-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF Relay Therapeutics, Inc. (US) 2025-04-30 EP disclosed
WO-2024006781-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-01-04 WO disclosed